Home » Authors » Jennifer Boggs

Articles by Jennifer Boggs

VioQuest Gets Cancer Products Through Greenwich Merger

May 9, 2005

By Jennifer Boggs

Bayhill Therapeutics Raises $35M In Series B For Autoimmune Drugs

May 6, 2005

By Jennifer Boggs

Bayhill Therapeutics Raises $35M In Series B For Autoimmune Drugs

May 6, 2005

By Jennifer Boggs

Cerovive Hits Primary Endpoint In Stroke Study; Renovis Soars

May 5, 2005

By Jennifer Boggs

Cerovive Hits Primary Endpoint In Stroke Study; Renovis Soars

May 5, 2005

By Jennifer Boggs

InKine Files NDA For Bowel Cleansing Product INKP-102

May 4, 2005

By Jennifer Boggs

InKine Files NDA For Bowel Cleansing Product INKP-102

May 4, 2005

By Jennifer Boggs

Conforma Adding $11M To Series C For Hsp90 Drugs

May 3, 2005

By Jennifer Boggs

Conforma Adding $11M To Series C For Hsp90 Drugs

May 3, 2005

By Jennifer Boggs

Stressgen Cuts Staff, Saving Resources For HPV Vaccine

April 29, 2005

By Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...